Cargando…

Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers

BACKGROUND: The rate of toxic deaths related to induction chemotherapy in the treatment of locally advanced head and neck cancers is unacceptable and calls into question this therapeutic strategy, which is however highly effective in terms of rate and speed of response. The purpose of the study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernadach, Maureen, Lapeyre, Michel, Dillies, Anne-Françoise, Miroir, Jessica, Casile, Melanie, Moreau, Juliette, Molnar, Ioana, Ginzac, Angeline, Pham-Dang, Nathalie, Saroul, Nicolas, Durando, Xavier, Biau, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025378/ https://www.ncbi.nlm.nih.gov/pubmed/33827483 http://dx.doi.org/10.1186/s12885-021-08128-5

Ejemplares similares

Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial
por: Ginzac, Angeline, et al.
Publicado: (2023)

Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy
por: Mione, Cécile, et al.
Publicado: (2023)

Adapted Physical Activity for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Trastuzumab Against HER2 (APACAN2): A Protocol for a Feasibility Study
por: Ginzac, Angeline, et al.
Publicado: (2021)

Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplanar arcs and acute toxicity outcomes from the STEREOPOSTOP GORTEC 2017–03 phase 2 trial
por: Biau, Julian, et al.
Publicado: (2022)

A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial
por: Biau, Julian, et al.
Publicado: (2020)

Sister Mary Joseph Nodules: A Case Report about a Rare Location of Skin Metastasis
por: Leyrat, Brice, et al.
Publicado: (2021)

Preoperative stereotactic radiosurgery for brain metastases: the STEP study protocol for a multicentre, prospective, phase-II trial
por: Ginzac, Angeline, et al.
Publicado: (2021)

Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report
por: Wong-Chong, Jonathan, et al.
Publicado: (2021)

XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer
por: Veyssière, Hugo, et al.
Publicado: (2021)

Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study
por: Herrmann, Tressie, et al.
Publicado: (2021)

Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
por: Thivat, Emilie, et al.
Publicado: (2023)

Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors
por: Leyrat, Brice, et al.
Publicado: (2022)

Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study
por: Hsieh, Ching-Yun, et al.
Publicado: (2020)

A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients
por: Ginzac, Angeline, et al.
Publicado: (2020)

RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire
por: Veyssiere, Hugo, et al.
Publicado: (2023)

hPG(80) (circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study
por: Casile, Melanie, et al.
Publicado: (2023)

Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
por: Fayette, Jérôme, et al.
Publicado: (2016)

Durable Response to Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring MET Intron 14 Mutation: A Case Report
por: Leyrat, Brice, et al.
Publicado: (2021)

Fractionated stereotactic radiotherapy of benign skull-base tumors: a dosimetric comparison of volumetric modulated arc therapy with Rapidarc® versus non-coplanar dynamic arcs
por: Martin, Fanny, et al.
Publicado: (2016)

INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer
por: Veyssière, Hugo, et al.
Publicado: (2021)

Quality of life for older patients with cancer: a review of the evidence supporting melatonin use
por: Ginzac, Angeline, et al.
Publicado: (2020)

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma
por: Leduc, Charlotte, et al.
Publicado: (2018)

PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer
por: Lusho, Sejdi, et al.
Publicado: (2020)

Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Charalambakis, Nikolaos, et al.
Publicado: (2013)

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Addition of Nimotuzumab to Standard TPF Regimen in Locally Advanced Head and Neck Cancer: A Single Institutional Study
por: Koramati, Samuel Luke, et al.
Publicado: (2021)

A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas
por: Ansari, M, et al.
Publicado: (2011)

Significant Correlation Between Overall Survival and Mean Lung Dose in Lung Stereotactic Body Radiation Therapy (SBRT)
por: Dupic, Guillaume, et al.
Publicado: (2020)

Two postoperative chemotherapies for gastric cancer: FOLFOX4 vs. TPF
por: Xie, Honghu, et al.
Publicado: (2019)

In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation
por: Jun, Michelle, et al.
Publicado: (2023)

Intraprostatic Fiducials Compared with Bony Anatomy and Skin Marks for Image-Guided Radiation Therapy of Prostate Cancer
por: Moreau, Juliette, et al.
Publicado: (2017)

Comparison of TPF and TP Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma Based on TNM Stage and Pretreatment Systemic Immune-Inflammation Index
por: Xiong, Ying, et al.
Publicado: (2021)

Effect of CADM1 on TPF-induced chemotherapy in laryngeal squamous cell carcinoma
por: Nie, Jiani, et al.
Publicado: (2023)

Low p16 Cytoplasmic Staining Predicts Poor Treatment Outcome in Patients with p16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving TPF Induction Chemotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Serum Levels of Stromal Cell-Derived Factor-1α and Vascular Endothelial Growth Factor Predict Clinical Outcomes in Head and Neck Squamous Cell Carcinoma Patients Receiving TPF Induction Chemotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2022)

Assessment of the risk factors for impending fractures following radiotherapy for long bone metastases using CT scan-based virtual simulation: a retrospective study
por: Tatar, Zuzana, et al.
Publicado: (2014)

Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma
por: Shimanuki, Marie, et al.
Publicado: (2018)

Flavonoids isolated from Tridax procumbens (TPF) inhibit osteoclasts differentiation and bone resorption
por: Al Mamun, Md. Abdullah, et al.
Publicado: (2015)

Increased response to TPF chemotherapy promotes immune escape in hypopharyngeal squamous cell carcinoma
por: Li, Ruichen, et al.
Publicado: (2023)

Long-Term Survival and Prognostic Factors in Locoregionally Advanced Nasopharyngeal Carcinoma Patients Treated with TPF Induction Chemotherapy followed by Cisplatin-Combined Concurrent Chemoradiotherapy
por: Zhang, Qun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ifv7ng5sdfkolm158ob6qcsbfj